These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 32979504)

  • 1. Gut microbiota and old age: Modulating factors and interventions for healthy longevity.
    Coman V; Vodnar DC
    Exp Gerontol; 2020 Nov; 141():111095. PubMed ID: 32979504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota and aging-A focus on centenarians.
    Cӑtoi AF; Corina A; Katsiki N; Vodnar DC; Andreicuț AD; Stoian AP; Rizzo M; Pérez-Martínez P
    Biochim Biophys Acta Mol Basis Dis; 2020 Jul; 1866(7):165765. PubMed ID: 32169505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
    Vemuri RC; Gundamaraju R; Shinde T; Eri R
    Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synbiotics, prebiotics and probiotics for people with chronic kidney disease.
    Cooper TE; Khalid R; Chan S; Craig JC; Hawley CM; Howell M; Johnson DW; Jaure A; Teixeira-Pinto A; Wong G
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013631. PubMed ID: 37870148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic-Therapy-Induced Gut Dysbiosis Affecting Gut Microbiota-Brain Axis and Cognition: Restoration by Intake of Probiotics and Synbiotics.
    Dahiya D; Nigam PS
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of probiotics, prebiotics, and synbiotics on the biochemical, clinical, and immunological markers, as well as on the gut microbiota of obese hosts.
    da Silva TF; Casarotti SN; de Oliveira GLV; Penna ALB
    Crit Rev Food Sci Nutr; 2021; 61(2):337-355. PubMed ID: 32156153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anorexia nervosa and gut microbiome: implications for weight change and novel treatments.
    Wei Y; Peng S; Lian C; Kang Q; Chen J
    Expert Rev Gastroenterol Hepatol; 2022 Apr; 16(4):321-332. PubMed ID: 35303781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of microbiome therapy on COVID-19-induced gut dysbiosis: A narrative and systematic review.
    Yousef M; Rob M; Varghese S; Rao S; Zamir F; Paul P; Chaari A
    Life Sci; 2024 Apr; 342():122535. PubMed ID: 38408636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiota shaping - the effects of probiotics, prebiotics, and fecal microbiota transplant on cognitive functions: A systematic review.
    Baldi S; Mundula T; Nannini G; Amedei A
    World J Gastroenterol; 2021 Oct; 27(39):6715-6732. PubMed ID: 34754163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over-feeding the gut microbiome: A scoping review on health implications and therapeutic perspectives.
    Barone M; D'Amico F; Fabbrini M; Rampelli S; Brigidi P; Turroni S
    World J Gastroenterol; 2021 Nov; 27(41):7041-7064. PubMed ID: 34887627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions on Gut Microbiota for Healthy Aging.
    Donati Zeppa S; Agostini D; Ferrini F; Gervasi M; Barbieri E; Bartolacci A; Piccoli G; Saltarelli R; Sestili P; Stocchi V
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synbiotics, prebiotics and probiotics for solid organ transplant recipients.
    Cooper TE; Scholes-Robertson N; Craig JC; Hawley CM; Howell M; Johnson DW; Teixeira-Pinto A; Jaure A; Wong G
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD014804. PubMed ID: 36126902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different Strategies Targeting Gut Microbiota for the Management of Several Disorders: A Sustainable Approach.
    Chowdhury M; Raj Chaudhary N; Kaur P; Goyal A; Sahu SK
    Infect Disord Drug Targets; 2024; 24(5):e160124225675. PubMed ID: 38317473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Dyslipidemia through Targeted Therapy of Gut Microbiota.
    Flaig B; Garza R; Singh B; Hamamah S; Covasa M
    Nutrients; 2023 Jan; 15(1):. PubMed ID: 36615885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiome-targeted therapies for Alzheimer's disease.
    Zhang T; Gao G; Kwok LY; Sun Z
    Gut Microbes; 2023 Dec; 15(2):2271613. PubMed ID: 37934614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the Gut Microbiota in Kidney Disease: The Future in Renal Nutrition and Metabolism.
    Lambert K; Rinninella E; Biruete A; Sumida K; Stanford J; Raoul P; Mele MC; Wang AY; Mafra D
    J Ren Nutr; 2023 Nov; 33(6S):S30-S39. PubMed ID: 37632511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the gut microbiota and sarcopenia: a systematic review.
    Liu C; Cheung WH; Li J; Chow SK; Yu J; Wong SH; Ip M; Sung JJY; Wong RMY
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1393-1407. PubMed ID: 34523250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics.
    Kaźmierczak-Siedlecka K; Daca A; Fic M; van de Wetering T; Folwarski M; Makarewicz W
    Gut Microbes; 2020 Nov; 11(6):1518-1530. PubMed ID: 32453670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients.
    Matijašić M; Meštrović T; Perić M; Čipčić Paljetak H; Panek M; Vranešić Bender D; Ljubas Kelečić D; Krznarić Ž; Verbanac D
    Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27104515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Effects of Gut Microbiota on Metabolic Syndrome: A Patent Review.
    Singhal S; Rani V
    Recent Adv Food Nutr Agric; 2022 Nov; 13(1):17-26. PubMed ID: 35307002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.